INDUSTRY NEWS

Arthur Cummings
Published: Thursday, December 10, 2015
FEMTOSECOND LASER PLATFORM
Heidelberg Engineering has signed a new agreement with Valeant to continue to supply the swept-source optical coherence tomography (OCT) module for the VICTUS® Femtosecond Laser Platform, commercialised under the Bausch+Lomb/Technolas brand.
The VICTUS® Femtosecond Laser Platform is used for cataract and corneal applications.
“Heidelberg Engineering delivers its advanced swept-source OCT module, which allows for real-time visualisation during every step of the surgery, from docking through planning and treatment,” said a company spokeswoman.
“The swept-source OCT module features high-quality images at video frame rate. It provides excellent imaging contrast and sensitivity for the autorecognition of key landmarks (pupil, lens, anterior and posterior capsule), boosting surgeons’ confidence and control during surgical procedures,” she said.
www.heidelbergengineering.com | www.valeant.com
MOBILE SOLUTION
The US Food and Drug Administration (FDA) has granted approval for use of the Ziemer FEMTO LDV Z8 in the USA.
“The FEMTO LDV Z8 was launched in Europe and selected Asian countries in mid-2014, with adoption steadily increasing since that time. It is the first truly mobile femtosecond laser solution for refractive, cornea and cataract procedures to be performed on an all-in-one system,” said a spokeswoman for Ziemer Ophthalmic Systems AG.
Zeimer say the FEMTO LDV Z8 uses unique technology that provides precision in the cornea and power in the lens, with use of adjustable pulse energy combined with a high repetition rate to provide a precise capsulotomy and lens fragmentation.
www.femtoldv.com
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.